NCT01207492 2026-02-20
Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
5 trialsNCT05349643 2024-07-05
A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
AmMax Bio, Inc.
Phase 2 Completed
NCT04731675 2024-06-27
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee
AmMax Bio, Inc.
Phase 2 Completed
NCT01643850 2021-01-05
MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
Novartis
Phase 2 Completed
NCT01261429 2013-04-16
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)
Centre Leon Berard
Phase 2 Completed